Charles C Engel1, Brett Litz2, Kathryn M Magruder3, Elizabeth Harper4, Kristie Gore4, Nathan Stein2, Derik Yeager3, Xian Liu5, T Ray Coe6. 1. Department of Psychiatry, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, USA. Electronic address: cengel@rand.org. 2. Massachusetts Veterans Epidemiological Research and Information Center, VA Boston Healthcare System, 150 S. Huntington Ave, Jamaica Plain, MA, USA; Department of Psychiatry, Boston University, 715 Albany St., M-8th Floor, Boston, MA, USA. 3. Ralph H. Johnson VA Medical Center, 109 Bee Street, Charleston, SC, USA; Department of Psychiatry, Medical University of South Carolina, 67 President Street, Charleston, SC, USA. 4. Deployment Health Clinical Center, Walter Reed National Military Medical Center, Building 8, 2nd Floor, Room 2220, 8901 Wisconsin Avenue, Bethesda, MD, USA. 5. Department of Psychiatry, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, USA; Deployment Health Clinical Center, Walter Reed National Military Medical Center, Building 8, 2nd Floor, Room 2220, 8901 Wisconsin Avenue, Bethesda, MD, USA; Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Department of Psychiatry, 4301 Jones Bridge Road, Bethesda, MD, USA. 6. Womack Army Medical Center, 2817 Reilly Rd, Fort Bragg, NC, USA.
Abstract
OBJECTIVE: This randomized controlled trial examined the effectiveness of a nurse assisted online cognitive-behavioral self-management intervention for war-related posttraumatic stress disorder (PTSD), compared to optimized usual primary care PTSD Treatment (OUC) to reduce PTSD symptoms. METHOD:Participants were 80 veterans of recent military conflicts with PTSD as assessed by the PTSD Checklist (PCL) seeking primary care treatment at one of three Veterans Affairs (VA) and four Army clinics. DESTRESS-PC consisted of logins to a secure website three times per week for 6 weeks with monitoring by a study nurse. All participants received nurse care management in the form of phone check-ins every two weeks and feedback to their primary care providers. Blinded raters assessed outcomes 6, 12, and 18 weeks post-randomization. RESULTS: DESTRESS-PC was associated with a significantly greater decrease in PTSD symptoms compared to OUC (F(3, 186)=3.72, p=.012). The effect was largest at the 12-week assessment (∆PCL=12.6±16.6 versus 5.7±12.5, p<0.05) with the treatment effect disappearing by the 18-week follow-up. Notably, there was a dose effect; number of logins correlated significantly with PTSD outcomes, with more logins associated with greater PTSD symptom improvement. None of the secondary outcomes (depression, anxiety, somatic symptoms, and functional status) showed statistically significant improvement; however, the treatment effect on depression approached significance (F(3, 186)=2.17, p=.093). CONCLUSIONS: DESTRESS-PC shows promise as a means of delivering effective, early PTSD treatment in primary care. Larger trials are needed.
RCT Entities:
OBJECTIVE: This randomized controlled trial examined the effectiveness of a nurse assisted online cognitive-behavioral self-management intervention for war-related posttraumatic stress disorder (PTSD), compared to optimized usual primary care PTSD Treatment (OUC) to reduce PTSD symptoms. METHOD:Participants were 80 veterans of recent military conflicts with PTSD as assessed by the PTSD Checklist (PCL) seeking primary care treatment at one of three Veterans Affairs (VA) and four Army clinics. DESTRESS-PC consisted of logins to a secure website three times per week for 6 weeks with monitoring by a study nurse. All participants received nurse care management in the form of phone check-ins every two weeks and feedback to their primary care providers. Blinded raters assessed outcomes 6, 12, and 18 weeks post-randomization. RESULTS: DESTRESS-PC was associated with a significantly greater decrease in PTSD symptoms compared to OUC (F(3, 186)=3.72, p=.012). The effect was largest at the 12-week assessment (∆PCL=12.6±16.6 versus 5.7±12.5, p<0.05) with the treatment effect disappearing by the 18-week follow-up. Notably, there was a dose effect; number of logins correlated significantly with PTSD outcomes, with more logins associated with greater PTSD symptom improvement. None of the secondary outcomes (depression, anxiety, somatic symptoms, and functional status) showed statistically significant improvement; however, the treatment effect on depression approached significance (F(3, 186)=2.17, p=.093). CONCLUSIONS: DESTRESS-PC shows promise as a means of delivering effective, early PTSD treatment in primary care. Larger trials are needed.
Authors: Alfred Lange; Deirdre Rietdijk; Milena Hudcovicova; Jean-Pierre van de Ven; Bart Schrieken; Paul M G Emmelkamp Journal: J Consult Clin Psychol Date: 2003-10
Authors: Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006
Authors: Lisa S Meredith; Eunice Wong; Karen Chan Osilla; Margaret Sanders; Mahlet G Tebeka; Bing Han; Stephanie L Williamson; Thomas W Carton Journal: Med Care Date: 2022-03-01 Impact factor: 2.983
Authors: Natalie Simon; Lindsay Robertson; Catrin Lewis; Neil P Roberts; Andrew Bethell; Sarah Dawson; Jonathan I Bisson Journal: Cochrane Database Syst Rev Date: 2021-05-20